192 related articles for article (PubMed ID: 32809822)
1. Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow.
Blaschke CRK; Black AP; Mehta AS; Angel PM; Drake RR
J Am Soc Mass Spectrom; 2020 Dec; 31(12):2511-2520. PubMed ID: 32809822
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Multiple Glycosidase and Chemical Stabilization Strategies for N-Glycan Isomer Detection by Mass Spectrometry Imaging in Formalin-Fixed, Paraffin-Embedded Tissues.
West CA; Lu X; Grimsley G; Norris-Caneda K; Mehta AS; Angel PM; Drake RR
Methods Mol Biol; 2021; 2271():303-316. PubMed ID: 33908016
[TBL] [Abstract][Full Text] [Related]
3. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues.
Powers TW; Jones EE; Betesh LR; Romano PR; Gao P; Copland JA; Mehta AS; Drake RR
Anal Chem; 2013 Oct; 85(20):9799-806. PubMed ID: 24050758
[TBL] [Abstract][Full Text] [Related]
4. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.
Powers TW; Holst S; Wuhrer M; Mehta AS; Drake RR
Biomolecules; 2015 Oct; 5(4):2554-72. PubMed ID: 26501333
[TBL] [Abstract][Full Text] [Related]
5. Antibody Panel Based N-Glycan Imaging for N-Glycoprotein Biomarker Discovery.
Black AP; Angel PM; Drake RR; Mehta AS
Curr Protoc Protein Sci; 2019 Dec; 98(1):e99. PubMed ID: 31721442
[TBL] [Abstract][Full Text] [Related]
6. Array-Based N-Glycan Profiling of Cells in Culture.
Angel PM; Mehta AS; Drake RR
Methods Mol Biol; 2021; 2271():331-342. PubMed ID: 33908018
[TBL] [Abstract][Full Text] [Related]
7. Novel Combined Enzymatic Approach to Analyze Nonsialylated N-Linked Glycans through MALDI Imaging Mass Spectrometry.
DelaCourt AT; Liang H; Drake RR; Angel PM; Mehta AS
J Proteome Res; 2022 Aug; 21(8):1930-1938. PubMed ID: 35766466
[TBL] [Abstract][Full Text] [Related]
8. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
9. A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging.
Black AP; Liang H; West CA; Wang M; Herrera HP; Haab BB; Angel PM; Drake RR; Mehta AS
Anal Chem; 2019 Jul; 91(13):8429-8435. PubMed ID: 31177770
[TBL] [Abstract][Full Text] [Related]
10. Improved and semi-automated reductive β-elimination workflow for higher throughput protein O-glycosylation analysis.
Kotsias M; Kozak RP; Gardner RA; Wuhrer M; Spencer DIR
PLoS One; 2019; 14(1):e0210759. PubMed ID: 30653606
[TBL] [Abstract][Full Text] [Related]
11. Altered N-linked glycosylation in endometrial cancer.
Mittal P; Briggs M; Klingler-Hoffmann M; Kaur G; Packer NH; Oehler MK; Hoffmann P
Anal Bioanal Chem; 2021 Apr; 413(10):2721-2733. PubMed ID: 33222001
[TBL] [Abstract][Full Text] [Related]
12. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
[TBL] [Abstract][Full Text] [Related]
13. New Enzymatic Approach to Distinguish Fucosylation Isomers of N-Linked Glycans in Tissues Using MALDI Imaging Mass Spectrometry.
West CA; Liang H; Drake RR; Mehta AS
J Proteome Res; 2020 Aug; 19(8):2989-2996. PubMed ID: 32441096
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
[TBL] [Abstract][Full Text] [Related]
15. Microwave-assisted deglycosylation for rapid and sensitive analysis of N-glycans via glycosylamine derivatization.
Wu Y; Wang C; Luo J; Liu Y; Zhang L; Xia Y; Feng X; Liu BF; Lin Y; Liu X
Anal Bioanal Chem; 2017 Jun; 409(16):4027-4036. PubMed ID: 28417175
[TBL] [Abstract][Full Text] [Related]
16. Automated measurement of permethylated serum N-glycans by MALDI-linear ion trap mass spectrometry.
Guillard M; Gloerich J; Wessels HJ; Morava E; Wevers RA; Lefeber DJ
Carbohydr Res; 2009 Aug; 344(12):1550-7. PubMed ID: 19577739
[TBL] [Abstract][Full Text] [Related]
17. Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.
Blaschke CRK; McDowell CT; Black AP; Mehta AS; Angel PM; Drake RR
Clin Lab Med; 2021 Jun; 41(2):247-266. PubMed ID: 34020762
[TBL] [Abstract][Full Text] [Related]
18. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of isomeric N-glycan structures by normal-phase liquid chromatography-MALDI-TOF/TOF tandem mass spectrometry.
Maslen S; Sadowski P; Adam A; Lilley K; Stephens E
Anal Chem; 2006 Dec; 78(24):8491-8. PubMed ID: 17165844
[TBL] [Abstract][Full Text] [Related]
20. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.
Morelle W; Faid V; Chirat F; Michalski JC
Methods Mol Biol; 2009; 534():5-21. PubMed ID: 19277556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
